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1. To construct and populate a research database describing 
clinical features and pregnancy outcomes among women 
treated at the Pregnancy Hypertension Kidney Center
2. Determine if there is an association between blood pressure 
at the initial PHKC visit and the subsequent development of 
preeclampsia among pregnant women followed in the PHKC 
program
The PHKC database includes data from 112 subjects. Data collected 
includes 262 fields in 5 forms.  Table 1 shows demographic and 
clinical characteristics of the patient population.  66% of subjects had 
chronic hypertension; 25% developed preeclampsia.  The most 
common reason for PHKC referral was chronic kidney disease.
There was no statistically significant difference in systolic blood 
pressure in women who did vs those that did not go on to develop 
preeclampsia.  However, the diastolic blood pressure was 
significantly higher in women who later developed preeclampsia, as 
compared to those that did not.   Hence, women diagnosed with 
preeclampsia did on average have a higher diastolic measurement at 
their initial visit than those who were not diagnosed with 
preeclampsia.
We may have failed to detect a true difference in systolic blood 
pressure due to the following limitations:
– small sample size, 
– the nature of the research question prevented randomization
– women with pre-existing hypertension are on medication to control it
• 41% of women diagnosed with preeclampsia were on 
medication to control blood pressure at the time of the 
readings
1. Build and refine the database using RedCap, a web-
based research database platform
2. Collect data from the electronic medical record, including 
EHMR, CE, CPO, EPIC.
3. Configure relevant data for statistical analysis
4. Conduct an independent subjects t-test comparing the 
mean systolic and diastolic blood pressure in women who 
were diagnosed with preeclampsia vs. those who were 
not
– Conditions: we are assuming independence, 
normality, and identical population variance
We succeeded in building a database describing the PHKC patient 
population, which will be used in future research studies.  We found a 
significant association between diastolic blood pressure at initial PHKC 
visit and later development of preeclampsia. Next steps could include 
expanding the database, or focusing on patients who only had 
hypertension rather than a wide range of kidney problems. Future 
analyses could control for the use of hypertension medications in order 
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Table 1: Study demographics at baseline 






Current tobacco use 12 (12.4%)
Preexisting diabetes mellitus 8 (8.2%)
Hypertension 64 (66%)
Chronic kidney disease (CKD) 61 (62.9%)
CKD etiology
Diabetic nephropathy 5 (8.2%)
Lupus nephritis 6 (9.8%)
Polycystic kidney disease 12 (19.7%)
Reflux nephropathy 3 (4.9%)
FSGS (Focal Segmental Glomersclerosis) 2 (3.3%)
IgA Nephropathy 2 (3.3%)







Gestational age at 1st PHKC visit (median, range) 19.70 (31.70)
Systolic BP at 1st PHKC visit (median, range) 124.50 (60.00)




Calcium channel blocker 8 (8.4%)
Thiazide diuretic 4 (4.2%)
Hydralazine 1 (3.0%)
None 61 (64.2%)
Serum creatinine (mean, SD) 0.6 (1.53)















The Pregnancy Hypertension Kidney Center (PHKC) is a multi-
disciplinary program started in 2012 to manage pregnancies 
that are at high risk due to hypertension or kidney disease. 
Pregnant patients with hypertension and/or kidney disease. 
were managed by the program. High blood pressure and 
protein in the urine are symptoms that can eventually turn into 
preeclampsia, a syndrome that can cause serious maternal or 
fetal complications.¹ The presence of hypertension in 
pregnancy is dangerous in general, with a strong association of 
preeclampsia complications.² Different kidney diseases can put 
mothers at a higher risk for developing preeclampsia, but even 
healthy mothers have some risk. 
The goal of this project was to develop a database to describe 
the PHKC patient population and to allow for research 
investigations.  Specifically, we seek to evaluate the association 
between blood pressure at initial PHKC visit and subsequent 
development of preeclampsia.
